Response to neoadjuvant chemotherapy in ICON8: A GCIG phase III randomised trial evaluating weekly dose-dense chemotherapy integration in first-line epithelial ovarian/fallopian tube/primary peritoneal carcinoma (EOC) treatment
Main Authors: | , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Conference item |
Published: |
Oxford University Press
2018
|